
IMHOTEP, PJP, and more
May 14, 2026 - 00:09:59
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
We review the recent ASCENT-04/Keynote-D19 publication of sacituzuab govitecan + pembrolizumab for PD-L1 CPS of 10% and above TNBC compared to chemo + pembrolizumab alone. Also, a quick recap of ASCO GI earlier this mont...
Sacituzumab govitecan + pembrolizumab and ASCO GI '26 is an episode from OncoPharm by OncoPharmPod. We review the recent ASCENT-04/Keynote-D19 publication of sacituzuab govitecan + pembrolizumab for PD-L1 CPS of 10% and above TNBC compared...
This episode belongs to OncoPharm.
Use the player on this page to stream the episode online.
Published Jan 22, 2026, 00:17:50 long, audio available.
We review the recent ASCENT-04/Keynote-D19 publication of sacituzuab govitecan + pembrolizumab for PD-L1 CPS of 10% and above TNBC compared to chemo + pembrolizumab alone. Also, a quick recap of ASCO GI earlier this month with mentions of zanidatamab and zolbetuximab. Finally, a check-in on The Pitt.
You can listen to Sacituzumab govitecan + pembrolizumab and ASCO GI '26 online on Radio and Podcast. Open the player on this page to stream the available audio.
Sacituzumab govitecan + pembrolizumab and ASCO GI '26 is an episode from OncoPharm by OncoPharmPod.
This episode is 00:17:50 long.
This episode was published on Jan 22, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from OncoPharm when more episodes are available from the podcast feed.
You can listen to Sacituzumab govitecan + pembrolizumab and ASCO GI '26 on this page when the episode audio is available from the podcast feed.
Sacituzumab govitecan + pembrolizumab and ASCO GI '26 is from OncoPharm by OncoPharmPod.
Published Jan 22, 2026 and 00:17:50 long